Screener
GeneDx Holdings WGS Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
FAQ
- What is GeneDx Holdings's restricted cash?
- GeneDx Holdings (WGS) reported restricted cash of $992K in Q1 2026.
- How has GeneDx Holdings's restricted cash changed year-over-year?
- GeneDx Holdings's restricted cash increased by 0.2% year-over-year, from $990K to $992K.
- What is the long-term trend for GeneDx Holdings's restricted cash?
- Over 5 years (2020 to 2025), GeneDx Holdings's restricted cash has grown at a 2.0% compound annual growth rate (CAGR), from $900K to $992K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about GeneDx Holdings's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude